In line with evidence on the role of PAX2 in endometrial cancer, we studied the effect of downregulating expression levels of PAX2 in Ishikawa cells using a mix of specific siRNAs that produced a marked reduction of its transcript and protein (Figure 5G). This evidence concerns the gene PAX2 and endometrial cancer.